Friday 6 November 2026 Export ABBV’s income statement to Excel — free account

AbbVie Inc.

ABBV Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024.

Revenue: +10.3%
EPS: +2,270.0%
Free cash flow: +9.97%
Total debt: +17.7%

Quarter to September 2026, against a year earlier

288.74 6.09 −2.07%

Follow ABBV

Alert me

Market cap: $509.5B
P/E: 49.7×
Fwd P/E: 38.6×
Dividend yield: 2.40%
F-score: 8/9
Altman Z: 2.31
Beneish M: −2.86
Dividend safety: 44/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

AbbVie Inc. (ABBV) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, AbbVie Inc. (ABBV) trades at a P/E ratio of 49.7×. Over the past ten years it has ranged from 12.2× (March 2020) to 185× (October 2025); the current reading is higher than 72% of that period. That is above the Drug Manufacturers General industry median of 26.6× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ABBV/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="AbbVie Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ABBV/metrics/pe-ratio">AbbVie Inc. (ABBV) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	96.8×	30.76%
FY2024	74.0×	26.48%
FY2023	58.5×	138.31%
FY2022	24.6×	17.02%
FY2021	21.0×	(43.97%)
FY2020	37.5×	123.42%
FY2019	16.8×	(34.88%)
FY2018	25.8×	(13.91%)
FY2017	29.9×	73.98%
FY2016	17.2×	(9.45%)

Period	P/E ratio	Change
Sep 2026	45.0×	(36.66%)
Jun 2026	71.1×	(33.65%)
Mar 2026	107×	10.66%
Dec 2025	96.8×	(44.80%)
43 more quarters	Free account

Against its own ten years

Low 12.2× High 185×

Ten-year median 27.8×

Current reading's percentile 76

Company	P/E ratio
GILD Gilead Sciences, Inc. compare	n/m
AZN AstraZeneca PLC compare	26.3×
AMGN Amgen Inc. compare	26.6×
NVS Novartis AG compare	30.9×
JNJ Johnson & Johnson compare	41.3×
PFE Pfizer Inc. compare	42.2×
LLY Eli Lilly and Company compare	44.5×
ABBV AbbVie Inc.	49.7×
MRK Merck & Co., Inc. compare	118×
Drug Manufacturers General industry median	26.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

AbbVie Inc. (ABBV) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ABBV

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ABBV

Stockrow Weekly